Matinas BioPharma Holdings, Inc.
MTNB
$2.13
$0.3922.41%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -54.41% | -14.62% | -47.05% | -40.74% | -36.42% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -24.84% | -73.09% | -60.22% | -48.00% | -35.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | -52.45% | -26.65% | -48.37% | -41.26% | -36.31% |
|
|
|||||
| Total Current Assets | -52.45% | -26.65% | -48.37% | -41.26% | -36.31% |
| Net Property, Plant & Equipment | -64.08% | -57.47% | -56.95% | -18.40% | -17.27% |
| Long-term Investments | -- | -- | -- | 0.00% | 0.00% |
| Goodwill | -- | -- | -- | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -21.36% | -23.53% | -23.53% | 0.00% | 0.00% |
| Total Assets | -53.11% | -38.63% | -49.65% | -30.93% | -28.39% |
|
|
|||||
| Total Accounts Payable | -29.83% | -40.38% | -81.52% | -58.20% | -60.60% |
| Total Accrued Expenses | -44.87% | 40.52% | 24.74% | -40.98% | 5.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.45% | 15.74% | 15.89% | 15.86% | 16.15% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -25.42% | 12.86% | 1.68% | -34.22% | -7.61% |
|
|
|||||
| Total Current Liabilities | -25.42% | 12.86% | 1.68% | -34.22% | -7.61% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -32.46% | -29.23% | -26.49% | -24.03% | -21.97% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -24.63% | 366.28% | -24.63% | 0.00% | 0.00% |
| Total Liabilities | -28.75% | 14.11% | -13.78% | -27.75% | -14.73% |
|
|
|||||
| Common Stock & APIC | 3.94% | 5.95% | 6.34% | 6.92% | 7.11% |
| Retained Earnings | -10.48% | -11.07% | -13.81% | -12.41% | -13.95% |
| Treasury Stock & Other | -- | -- | -- | -- | 90.08% |
| Total Common Equity | -59.82% | -56.93% | -60.56% | -31.84% | -31.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -59.82% | -56.93% | -60.56% | -31.84% | -31.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -59.82% | -56.93% | -60.56% | -31.84% | -31.42% |
|
|
|||||